#Ireland #Dublin #quarterly dividend #Perrigo Company #Consumer Self-Care

Perrigo Company Declares Dividend

On July 30, 2025, Perrigo Company plc, listed under the NYSE as PRGO, announced an important financial decision: the Board of Directors has declared a quarterly dividend of $0.290 per share. This payment is to be made on September 16, 2025, to shareholders who hold the stock as of August 29, 2025. This move showcases Perrigo's ongoing commitment to providing value to its shareholders and reflects the firm’s continuous operation within the self-care product market.

Company Overview

Perrigo is recognized as a leading pure-play self-care company, boasting over 100 years of expertise. The company is a vital player in offering quality health and wellness products, primarily focusing on the North American and European markets. Its history of being a pioneer in the over-the-counter (OTC) self-care space emphasizes its long-standing dedication to enhancing consumer accessibility to health solutions without requiring prescriptions.

The diverse product line includes notable brands, such as Opill®, Mederma®, Compeed®, EllaOne®, and Jungle Formula®, catering to various health and wellness needs. Perrigo’s unique business strategy capitalizes on its complementary operations, where its cash-generating store brand private label offerings effectively support and empower investments in its leading brands.

Financial Health and Strategic Vision

Perrigo's dividend declaration is highly indicative of its strong financial health. By offering dividends, the company not only rewards its investors but signals confidence in its profitability and growth strategies. The decision to issue a quarterly dividend aligns with Perrigo’s strategy of sustaining shareholder value while continuing to invest in its brand portfolio and deepen its market presence.

As pressures in the global market increase, Perrigo aims to balance its growth initiatives with shareholder rewards meticulously. The company's ongoing investments in research and development are tailored to innovate and expand its product offerings, ensuring that it remains competitive within the self-care and wellness industries.

Looking Ahead

The market has seen a notable shift towards self-care products, spurred by greater awareness among consumers regarding their health and well-being. With this evolving landscape, Perrigo is strategically positioned to capitalize on these trends. The upcoming financial statements and quarterly earnings releases are anticipated with interest as they will provide deeper insights into Perrigo's future performance and ongoing initiatives.

Interested stakeholders and consumers can follow these developments through Perrigo’s official website, where they can also access comprehensive resources about the company’s products and financial health. Additionally, stakeholders are encouraged to review the company's filings with the United States Securities and Exchange Commission, accessible online, for further details regarding business strategies and financial projections.

Perrigo continues to be a prominent name in consumer self-care, blending rich experience with innovation to enhance health outcomes for consumers worldwide. As investors await the next dividend payments and future earnings releases, the company remains focused on providing better health solutions globally, ensuring a healthier future for all.

• ---

For more information, please visit Perrigo’s official website.
Press inquiries can be directed to Bradley Joseph, Vice President, or Nicholas Gallagher, Senior Manager in Global Investor Relations at Perrigo.